US Edition
News from EuropaWire.eu
We’ve assigned a rating of Unknown factuality to EuropaWire.eu. You can read more about how we’ve determined EuropaWire.eu’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top EuropaWire.eu News
European UnionSanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes
Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D patients Teizeild represents a potential significant change in the treatment of autoimmune T1D, preventing the natural disease progression protecting beta-cell function Paris, January 12, 2026. The European Commission has approved Teizeild (teplizuma…See the Story
Press Release: Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes
50% Center coverage: 10 sources
Europe · UkraineGerman defense concern Rheinmetall has announced the delivery of the first five Lynx KF41 infantry fighting vehicles (IFVs) at the beginning of this year, with the next step being the procurement of additional batches of such vehicles, including production in Ukraine.See the Story
Ukraine to Receive Its First Lynx KF41 IFVs in Early 2026 – Rheinmetall
67% Right coverage: 3 sources
